SI21507A - Postopek za pripravo spojin z ace inhibitornim delovanjem - Google Patents

Postopek za pripravo spojin z ace inhibitornim delovanjem Download PDF

Info

Publication number
SI21507A
SI21507A SI200300123A SI200300123A SI21507A SI 21507 A SI21507 A SI 21507A SI 200300123 A SI200300123 A SI 200300123A SI 200300123 A SI200300123 A SI 200300123A SI 21507 A SI21507 A SI 21507A
Authority
SI
Slovenia
Prior art keywords
preparation
compounds
ace inhibitory
activated
inhibitory activity
Prior art date
Application number
SI200300123A
Other languages
English (en)
Slovenian (sl)
Inventor
Branko Jenko
Original Assignee
LEK farmacevtska dru�ba d.d.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK farmacevtska dru�ba d.d. filed Critical LEK farmacevtska dru�ba d.d.
Priority to SI200300123A priority Critical patent/SI21507A/sl
Priority to EP04731808A priority patent/EP1628956B1/fr
Priority to DE602004030112T priority patent/DE602004030112D1/de
Priority to SI200431600T priority patent/SI1628956T1/sl
Priority to PCT/SI2004/000021 priority patent/WO2004101515A1/fr
Priority to US10/556,986 priority patent/US7671215B2/en
Priority to AT04731808T priority patent/ATE488498T1/de
Priority to RU2005139158/04A priority patent/RU2377236C2/ru
Publication of SI21507A publication Critical patent/SI21507A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200300123A 2003-05-16 2003-05-16 Postopek za pripravo spojin z ace inhibitornim delovanjem SI21507A (sl)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SI200300123A SI21507A (sl) 2003-05-16 2003-05-16 Postopek za pripravo spojin z ace inhibitornim delovanjem
EP04731808A EP1628956B1 (fr) 2003-05-16 2004-05-07 Procede de preparation de composes ayant une action inhibitrice sur ace
DE602004030112T DE602004030112D1 (de) 2003-05-16 2004-05-07 Verfahren zur herstellung von ace hemmern
SI200431600T SI1628956T1 (sl) 2003-05-16 2004-05-07 Postopek za pripravo spojin z ACE inhibitornim delovanjem
PCT/SI2004/000021 WO2004101515A1 (fr) 2003-05-16 2004-05-07 Procede de preparation de composes ayant une action inhibitrice sur ace
US10/556,986 US7671215B2 (en) 2003-05-16 2004-05-07 Process for the preparation of compounds having an ace inhibitory action
AT04731808T ATE488498T1 (de) 2003-05-16 2004-05-07 Verfahren zur herstellung von ace hemmern
RU2005139158/04A RU2377236C2 (ru) 2003-05-16 2004-05-07 Способ получения соединений, обладающих апф ингибиторной активностью

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200300123A SI21507A (sl) 2003-05-16 2003-05-16 Postopek za pripravo spojin z ace inhibitornim delovanjem

Publications (1)

Publication Number Publication Date
SI21507A true SI21507A (sl) 2004-12-31

Family

ID=33448812

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200300123A SI21507A (sl) 2003-05-16 2003-05-16 Postopek za pripravo spojin z ace inhibitornim delovanjem
SI200431600T SI1628956T1 (sl) 2003-05-16 2004-05-07 Postopek za pripravo spojin z ACE inhibitornim delovanjem

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200431600T SI1628956T1 (sl) 2003-05-16 2004-05-07 Postopek za pripravo spojin z ACE inhibitornim delovanjem

Country Status (7)

Country Link
US (1) US7671215B2 (fr)
EP (1) EP1628956B1 (fr)
AT (1) ATE488498T1 (fr)
DE (1) DE602004030112D1 (fr)
RU (1) RU2377236C2 (fr)
SI (2) SI21507A (fr)
WO (1) WO2004101515A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2468724T3 (pl) * 2006-12-21 2016-05-31 Zealand Pharma As Synteza związków pirolidynowych
US20090076126A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched enalapril
US8288565B2 (en) 2009-07-16 2012-10-16 Abbott Laboratories Process for the synthesis of (2S,3AR,7AS)-octahydro-1H-indole carboxylic acid as an intermediate for trandolapril
EP2906536B1 (fr) * 2012-10-10 2018-03-14 Piramal Enterprises Limited Procédé amélioré de préparation d'un intermédiaire de périndopril

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL4915C (fr) 1913-08-18
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
US5864040A (en) 1996-01-11 1999-01-26 American Home Products Corporation Benzimidazole phosphono-amino acids
GB9710612D0 (en) 1997-05-23 1997-07-16 Glaxo Group Ltd Synthesis of acridine derivatives
KR20020084273A (ko) 2000-03-31 2002-11-04 화이자 프로덕츠 인코포레이티드 신규한 피페라진 유도체
GB2375762B (en) * 2001-05-21 2003-10-01 Fermenta Biotech Ltd Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters
US7214769B2 (en) 2001-05-23 2007-05-08 The Curators Of The University Of Missouri Method for inverse solid phase synthesis of peptides
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
GB0119795D0 (en) 2001-08-14 2001-10-03 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
ATE488498T1 (de) 2010-12-15
US20070072919A1 (en) 2007-03-29
EP1628956B1 (fr) 2010-11-17
US7671215B2 (en) 2010-03-02
SI1628956T1 (sl) 2011-03-31
WO2004101515A1 (fr) 2004-11-25
EP1628956A1 (fr) 2006-03-01
DE602004030112D1 (de) 2010-12-30
RU2005139158A (ru) 2007-06-27
RU2377236C2 (ru) 2009-12-27

Similar Documents

Publication Publication Date Title
JP3176619B2 (ja) 芳香族スルホンアミド化合物、阻害剤及びそれを含有する医薬組成物
JPH0144693B2 (fr)
EP2627636A1 (fr) Procédé pour la fabrication de bortézomib et intermédiaires pour le procédé
HU181087B (en) Process for producing mercapto-acyl-dipeptides
SI21507A (sl) Postopek za pripravo spojin z ace inhibitornim delovanjem
SK287067B6 (sk) Spôsob syntézy esterov N-[(S)-1-karboxybutyl]-(S)-alanínu a ich použitie pri syntéze perindoprilu
US20140142279A1 (en) Method for peptide synthesis
JPS61100564A (ja) ペプチドで置換された複素環免疫促進剤
JP2659990B2 (ja) 結晶性キナプリルおよびその製法
US7223872B2 (en) Process for the synthesis of perindopril and its pharmaceutically acceptable salts
SI21800A (sl) Nov postopek sinteze perindoprila
EP0080283B1 (fr) Tripeptides contenant la N-carboxyalcoylproline
PL185541B1 (pl) Sposób wytwarzania N-acetylo-(L)-4-cyjanofenyloalaniny i N-acetylo-(L)-p-amidynofenyloalaninocykloheksyloglicyno-beta-(3-N-metylopirydynio)-alaniny
KR100825537B1 (ko) 페린도프릴 및 이의 약학적으로 허용되는 염의 합성 방법
US4456594A (en) N-Carboxyalkylproline-containing tripeptides
JPH049800B2 (fr)
SI9600169A (en) Process for preparation of compounds with ace inhibitory effect
JPH0813835B2 (ja) ピログルタミン酸残基を有するトリペプチド誘導体
Kim et al. Benzotriazol-1-yl Diethyl Phosphate and Benzotriazol-1-yl Diphenyl Phosphate. New Convenient Reagents for the Peptide Synthesis
ES2473271T3 (es) Proceso de preparación de dimiracetam
EP1628995B1 (fr) Procede de preparation de perindopril utilisant des sels de tetramethyluronium comme reactifs de couplage
SI8811355A (en) Process for preparing of L-alanine-L-proline derivatives
CA2369267A1 (fr) Procede de production d'amidines
RU2190604C1 (ru) СПОСОБ ПОЛУЧЕНИЯ N-НИКОТИНОИЛ-γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ
JPS6248655A (ja) Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニルクロリド無機酸塩及びその製造法

Legal Events

Date Code Title Description
IF Valid on the event date
OO00 Grant of patent

Effective date: 20031011

KO00 Lapse of patent

Effective date: 20130523